FDA.reportPublic FDA data

Application 021036

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RELENZAZANAMIVIRPOWDER;INHALATION5MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021036-001RELENZAZANAMIVIR5MGPOWDER / INHALATIONRLD, RS1999-07-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N021036-001RELENZA5MGPOWDER / INHALATIONRLD, RS1999-07-26f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021036-001RELENZA5MGPOWDER / INHALATIONRLD, RS1999-07-26e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021036-001RELENZA5MGPOWDER / INHALATIONRLD, RS1999-07-26cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N021036-001RELENZA5MGPOWDER / INHALATIONRLD, RS1999-07-26a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RELENZAZANAMIVIRA-S Medication Solutionsb4e68930-4e6d-4d27-b1f0-abf60d12e28d2026-07-23Warnings, Adverse reactionsExact identifier
application applno (NDA): 021036
application number: NDA021036
RELENZAZANAMIVIRGlaxoSmithKline LLCd7c3bcc3-0c0d-4068-fd80-88cf54a376ef2023-10-24Warnings, Adverse reactionsExact identifier
application applno (NDA): 021036
application number: NDA021036
ndc (product): 0173-0681

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
0173-0681RELENZAzanamivirGlaxoSmithKline LLCNDACurrent
68258-3030RELENZAzanamivirDispensing Solutions Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
75942SUPPL 2023-10-25
75924SUPPL 2023-10-25
69045SUPPL2021-10-21
69031SUPPL2021-10-20
54698SUPPL2018-06-27
54691SUPPL2018-06-27
21364SUPPL2014-01-16
14218SUPPL2011-12-23
26554SUPPL2011-12-22
4122SUPPL2010-12-15
35949SUPPL2010-12-10
4121SUPPL2010-05-07
26553SUPPL2010-03-29
35948SUPPL2010-03-26
26552SUPPL2009-10-16
26551SUPPL2009-10-16
26548SUPPL2009-10-16
4118SUPPL2009-10-16
4116SUPPL2009-10-16
35947SUPPL2008-10-09
4120SUPPL2008-10-07
35946SUPPL2008-02-25
4119SUPPL2008-02-25
26550SUPPL2007-09-11
14217SUPPL2007-09-11
4117SUPPL2007-03-15
26549SUPPL2006-04-05
14216SUPPL2006-04-03
26546SUPPL2004-06-15
21363SUPPL2004-04-12
35944SUPPL2003-10-07
35945SUPPL2003-08-15
26547SUPPL2003-08-15
14215SUPPL2001-04-27
35943SUPPL2000-04-26
26545SUPPL2000-04-26
21362ORIG1999-07-26
14214ORIG1999-07-26
4115ORIG1999-07-26